Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) (COALITION-V)
Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19
Sponsor: Brazilian Research In Intensive Care Network
Listed as NCT04466540, this PHASE4 trial focuses on COVID-19 and remains completed. Sponsored by Brazilian Research In Intensive Care Network, it has been updated 8 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Apr 2022 — Jul 2024 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Sep 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Aug 2020 — Dec 2020 [monthly]
Recruiting PHASE4
First recorded
May 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brazilian Research In Intensive Care Network
- EMS S/A
- Hospital Alemão Oswaldo Cruz
- Hospital Israelita Albert Einstein
- Hospital Moinhos de Vento
- Hospital Sirio-Libanes
- Hospital do Coracao
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Araras, Brazil , Barbalha, Brazil , Barretos, Brazil , Barueri, Brazil , Belo Horizonte, Brazil , Bento Gonçalves, Brazil , Blumenau, Brazil , Botucatu, Brazil , Brusque, Brazil , Cachoeiro de Itapemirim, Brazil and 38 more locations